CytoSorbents Corp. (CTSO)

7.49
NASDAQ : Health Technology
Prev Close 7.63
Day Low/High 7.41 / 7.85
52 Wk Low/High 5.84 / 14.95
Avg Volume 113.90K
Exchange NASDAQ
Shares Outstanding 32.25M
Market Cap 246.06M
EPS -0.60
P/E Ratio N/A
Div & Yield N.A. (N.A)
4 Stocks Spiking on Big Volume: Arista Networks and More

4 Stocks Spiking on Big Volume: Arista Networks and More

Unusual volume can be a major signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.

Biotech Stock Mailbag: Small-Cap Rebound, Avanir, Ohr, CytoSorbents

Biotech Stock Mailbag: Small-Cap Rebound, Avanir, Ohr, CytoSorbents

Biotech columnist Adam Feuerstein answers readers' questions about health care.

CytoSorbents CEO Provides Exclusive Interview With MedGadget

CytoSorbents CEO Provides Exclusive Interview With MedGadget

Dr. Phillip Chan Discusses the Potential of CytoSorb(R) to Revolutionize Critical Care Medicine, the Strategy in Europe, and Plans for a US Pivotal Study

CytoSorbents Provides Corporate Update And Reports 2012 Year End Financial Results

CytoSorbents Provides Corporate Update And Reports 2012 Year End Financial Results

Q1 2013 CytoSorb(R) Product Revenue to Exceed Entire 2012 CytoSorb(R) Product Revenue

Photo Release -- CytoSorbents Provides Update On ISICEM 2013 Critical Care Conference

Photo Release -- CytoSorbents Provides Update On ISICEM 2013 Critical Care Conference

Significant Interest Generated from Distributors and Key Opinion Leaders